{
    "type": "ETF",
    "ucits": true,
    "fund_name": "UBS J.P. Morgan USD EM Diversified Bond 1-5 UCITS ETF",
    "replication_method": "physical",
    "leverage": false,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "complex_factors": [],
    "classification": "non-complex",
    "supporting_data": "The ETF is a UCITS-compliant bond ETF that tracks the J.P. Morgan USD EM Diversified 3% capped 1-5 Year Bond Index using a stratified sampling approach. The KIID and PRIIPs KID indicate that the fund achieves exposure predominantly through direct investment in bonds and transferable securities, with the possibility of limited derivative use for hedging or efficient portfolio management, but not as an inherent part of the investment strategy. There is no mention of synthetic replication, swap agreements, total return swaps, or counterparty risk exposure typical of synthetic ETFs. The replication method is physical stratified sampling as confirmed by the factsheet. The fund is not leveraged, does not use inverse or amplified exposure, and does not hold complex underlying assets such as contingent convertible bonds or CLOs. The risk profile is moderate (risk category 4 in KIID, but only 2 in PRIIPs KID, reflecting different methodologies), with no capital protection or structured features. Costs are straightforward with a TER of 0.38%, no performance fees, and no swap or derivative fees disclosed. The PRIIPs KID states the product is 'not simple and may be difficult to understand' but this is a standard warning for bond ETFs with emerging market exposure and currency hedging, not indicative of synthetic or leveraged complexity. The monthly factsheet confirms physical replication, no securities lending, and no synthetic swap usage. The fund uses currency forwards for hedging currency risk, which is a standard risk management technique and does not trigger 'derivatives' = true under MiFID II complexity rules. Overall, the ETF's structure, replication, and risk disclosures do not meet the MiFID II criteria for a complex financial instrument."
}